Zofin to Treat COVID-19 Long Haulers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to assess the safety and potential efficacy of Zofin administered intravenously in subjects experiencing prolonged symptoms (\> 6 weeks and \< 24 months) of COVID-19.
Epistemonikos ID: a76b527affb0902afcc43e4bc7fff2f22404483f
First added on: Feb 09, 2022